⌘K
Loading ticker…
As of 2026-08-24, Diebold Nixdorf, Incorporated (DBD) has a 3-month relative strength percentile of 34 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 48. The current market Stance is 47.8 (Neutral). Sector: Industrials, ranked 6 of 11. Average daily range 4.6%, relative volume 1.00×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
DBD appears in 1 ETF as of Jun 2026: PSC at 0.10% weight, $2M notional.
Held by 87 ETFs · $401M across latest filings · largest weight 1.25% (PRN).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PSC | 0.10% | $2M | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DBD Jan avg: 18.89% median: 3.33% win: 100% σ: 33.00% n: 4 2022-04-12 → 2026-07-31 | DBD Feb avg: 15.31% median: 12.17% win: 100% σ: 14.11% n: 4 2022-04-12 → 2026-07-31 | DBD Mar avg: -16.27% median: -3.43% win: 25% σ: 31.25% n: 4 2022-04-12 → 2026-07-31 | DBD Apr avg: -11.96% median: -8.07% win: 40% σ: 15.17% n: 5 2022-04-12 → 2026-07-31 | DBD May avg: -8.13% median: 5.64% win: 60% σ: 40.56% n: 5 2022-04-12 → 2026-07-31 | DBD Jun avg: -4.82% median: -3.63% win: 50% σ: 18.53% n: 4 2022-04-12 → 2026-07-31 | DBD Jul avg: 10.91% median: 7.39% win: 75% σ: 23.59% n: 4 2022-04-12 → 2026-07-31 | DBD Aug avg: 1760.80% median: 8.15% win: 100% σ: 3508.80% n: 4 2022-04-12 → 2026-07-31 (current) | DBD Sep avg: -7.64% median: -3.52% win: 25% σ: 15.75% n: 4 2022-04-12 → 2026-07-31 | DBD Oct avg: 2.40% median: 2.84% win: 100% σ: 1.65% n: 4 2022-04-12 → 2026-07-31 | DBD Nov avg: 7.65% median: 4.47% win: 50% σ: 20.66% n: 4 2022-04-12 → 2026-07-31 | DBD Dec avg: -5.72% median: -0.83% win: 50% σ: 20.48% n: 4 2022-04-12 → 2026-07-31 |